Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Wells

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmacology, Biochemistry, and Behavior|January 4, 2011
D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of responseEdward D Levin, Susan Slade, Corinne Wells, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2015
Bupropion-varenicline interactions and nicotine self-administration behavior in ratsBrandon J Hall, Susan Slade, Corinne Wells, et al.
Pharmacology, Biochemistry, and Behavior|November 18, 2023
Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D<sub>1</sub> antagonist-induced reduction of nicotine self-administration in female ratsSarabesh Natarajan, Grant Abass, Lucas Kim, et al.
Pharmacology, Biochemistry, and Behavior|February 23, 2019
Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in ratsAmir H Rezvani, Corinne Wells, Susan Slade, et al.
Pharmacology, Biochemistry, and Behavior|November 13, 2018
Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D<sub>1</sub> receptor antagonist SCH-23390 or the serotonin 5-HT<sub>2C</sub> agonist lorcaserinDevon DiPalma, Amir H Rezvani, Blair Willette, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2011
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female ratsEdward D Levin, Joshua E Johnson, Susan Slade, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Pentilludin reduces rat amphetamine and remifentail self-administration with good pharmacologic and toxicologic profilesGeorge Uhl, Balaji Kannan, Joungil Choi, et al.
European Journal of Pharmacology|June 24, 2015
Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female ratsEdward D Levin, Corinne Wells, Joshua E Johnson, et al.
Behavioural Brain Research|September 9, 2021
Chronic infusions of mecamylamine into the medial habenula: Effects on nicotine self-administration in ratsEdward D Levin, Corinne Wells, Susan Slade, et al.
Psychopharmacology|June 20, 2016
Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female ratsEdward D Levin, Brandon J Hall, Autri Chattopadhyay, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacology, Biochemistry, and Behavior|January 4, 2011
D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of responseEdward D Levin, Susan Slade, Corinne Wells, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2015
Bupropion-varenicline interactions and nicotine self-administration behavior in ratsBrandon J Hall, Susan Slade, Corinne Wells, et al.
Pharmacology, Biochemistry, and Behavior|November 18, 2023
Acute and chronic glutamate NMDA antagonist treatment attenuates dopamine D<sub>1</sub> antagonist-induced reduction of nicotine self-administration in female ratsSarabesh Natarajan, Grant Abass, Lucas Kim, et al.
Pharmacology, Biochemistry, and Behavior|February 23, 2019
Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in ratsAmir H Rezvani, Corinne Wells, Susan Slade, et al.
Pharmacology, Biochemistry, and Behavior|November 13, 2018
Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D<sub>1</sub> receptor antagonist SCH-23390 or the serotonin 5-HT<sub>2C</sub> agonist lorcaserinDevon DiPalma, Amir H Rezvani, Blair Willette, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2011
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female ratsEdward D Levin, Joshua E Johnson, Susan Slade, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Pentilludin reduces rat amphetamine and remifentail self-administration with good pharmacologic and toxicologic profilesGeorge Uhl, Balaji Kannan, Joungil Choi, et al.
European Journal of Pharmacology|June 24, 2015
Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female ratsEdward D Levin, Corinne Wells, Joshua E Johnson, et al.
Behavioural Brain Research|September 9, 2021
Chronic infusions of mecamylamine into the medial habenula: Effects on nicotine self-administration in ratsEdward D Levin, Corinne Wells, Susan Slade, et al.
Psychopharmacology|June 20, 2016
Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female ratsEdward D Levin, Brandon J Hall, Autri Chattopadhyay, et al.
Pageof 4